Clinical Characteristics and Outcomes in Patients With KRAS G12C Mutated Non-Small Cell Lung Cancer

被引：0
|
作者：
Pellini, B. [1 ]
Ganesan, V. [2 ]
Wan, F. [3 ]
Sankararaman, S. [4 ]
Manyanont, S. [4 ]
Akhave, N. [5 ]
Baggstrom, M. [4 ]
Ward, J. [4 ]
Waqar, S. [4 ]
Morgensztern, D. [4 ]
Govindan, R. [6 ]
Devarakonda, S. [4 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA
[2] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
[3] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO 14263 USA
[4] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Siteman Canc Ctr, St Louis, MO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Non-small cell lung cancer; KRAS G12C mutation; KRAS-mutant NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP07.13
引用
收藏
页码：S209 / S210
页数：2
相关论文
共 50 条
  • [41] Liquid biopsy to track KRAS G12C mutation at progressive disease in patients with advanced non-small cell lung cancer (NSCLC)
    De Renzi, G.
    Nicolazzo, C.
    Pisegna, S.
    Belardinilli, F.
    Bottillo, I.
    Grammatico, P.
    Giannini, G.
    Gelibter, A. J.
    Gazzaniga, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S983 - S983
  • [42] KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study
    Frost, Matilde Grupe
    Jensen, Kristoffer Jarlov
    Gotfredsen, Ditte Resendal
    Sorensen, Anne Mette Skov
    Ankarfeldt, Mikkel Zollner
    Louie, Karly S.
    Sroczynski, Nicholas
    Jakobsen, Erik
    Andersen, Jon Lykkegaard
    Jimenez-Solem, Espen
    Petersen, Tonny Studsgaard
    LUNG CANCER, 2023, 178 : 172 - 182
  • [43] Role of AXL activation on adaptive resistance to KRAS-G12C inhibitors in KRAS-G12C-mutated non-small cell lung cancer
    Yamada, T.
    Morimoto, K.
    Hirai, S.
    Katayama, Y.
    Kunimasa, K.
    Sasaki, T.
    Nishida, M.
    Watanabe, S.
    Shiotsu, S.
    Uehara, H.
    Takayama, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S194 - S194
  • [44] KRASG12C G12C Inhibitors in Non-Small Cell Lung Cancer: A Review
    Tang, Min
    Wu, Yijun
    Bai, Xiufeng
    Lu, You
    ONCOTARGETS AND THERAPY, 2024, 17 : 683 - 695
  • [45] Presentation and outcomes of KRAS G12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence
    Esfahanian, Niki
    Chan, Sze Wah Samuel
    Zhan, Luna J.
    Brown, M. Catherine
    Khan, Khaleeq
    Lee, Jae
    Balaratnam, Karmugi
    Yan, Elizabeth
    Parker, Jennifer
    Garcia-Pardo, Miguel
    Barghout, Samir H.
    Eng, Lawson
    Bradbury, Penelope A.
    Shepherd, Frances A.
    Leighl, Natasha B.
    Sacher, Adrian G.
    Snow, Stephanie
    Juergens, Rosalyn
    Liu, Geoffrey
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 37
  • [46] Oncogenic non-G12C KRAS mutations in KRAS G12C mutated lung adenocarcinomas in TRACERx and GENIE: A reservoir for intrinsic resistance to KRAS G12C inhibitors
    Marinelli, D.
    Pisegna, S.
    Giammaruco, M.
    Chesi, P.
    Mammone, G.
    Ceddia, S.
    Gazzaniga, P.
    Cortesi, E.
    Gelibter, A. J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1345 - S1346
  • [47] NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes
    Dehem, A.
    Mazieres, J.
    Chour, A.
    Guisier, F.
    Ferreira, M.
    Boussageon, M.
    Girard, N.
    Moro-Sibilot, D.
    Cadranel, J.
    Zalcman, G.
    Ricordel, C.
    Wislez, M.
    Munck, C.
    Poulet, C-H.
    Gauvain, C.
    Descarpentries, C.
    Wasielewski, E.
    Cortot, A. B.
    Baldacci, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1023 - S1024
  • [48] Real-world clinical characteristics and treatment (tx) outcomes by co-mutation status in patients (pts) with KRAS G12C- mutated non-small cell lung cancer (NSCLC)
    Negrao, Marcelo V.
    Wu, Wen-Hsing
    Lindsay, Colin R.
    Caparica, Rafael
    Pretre, Vincent
    Kang, Yehrim
    Caro, Nydia
    Farago, Anna
    Ye, Fen
    de Castro, Gilberto, Jr.
    CANCER RESEARCH, 2023, 83 (07)
  • [49] Prognostic Role of KRAS G12C Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Wankhede, Durgesh
    Bontoux, Christophe
    Grover, Sandeep
    Hofman, Paul
    DIAGNOSTICS, 2023, 13 (19)
  • [50] Lumykras® (Sotorasib) receives EU Approval for Female Patients with KRAS G12C Mutation-positive Non-small Cell Lung Cancer
    Freye, Reimund
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (1-2) : 73 - 73
12345